---
gsd_state_version: 1.0
milestone: v1.0-continuation
milestone_name: Existing Selemene wave completion
status: ready
stopped_at: Phase 02 verified complete; Phase 03 discussion and research next
last_updated: "2026-09-06T16:50:15.000Z"
last_activity: 2026-09-06 — Exact-head 16-job CI passed and Phase 02 verification closed
progress:
  total_phases: 7
  completed_phases: 2
  total_plans: 9
  completed_plans: 9
  percent: 29
---

# Project state

## Current Position

Phase: 03 (capability-and-contract-closure) — READY FOR DISCUSSION
Plan: 0 of TBD
Status: Phase 02 verified; Phase 03 discussion and research ready
Last activity: 2026-09-06 — GitHub run 34046002390 passed all 16 jobs at exact evidence head ba2d149

Progress: [███░░░░░░░] 29%

## Performance Metrics

| Plan | Duration | Tasks | Files |
|------|----------|-------|-------|
| Phase 02 P06 | 26m | 2 tasks | 16 files |
| Phase 02 P07 | 69m | 2 tasks | 17 files |

## Decisions

Reuse Waves 0–6 and stable GitHub issue IDs. ISA owns acceptance; GSD is the execution adapter. Discuss uses user-authorized recommended defaults, research and verification remain enabled. Local repairs continue; critical gates are held until exact artifacts are reviewable.

- [Phase 02]: Use the versioned engine registry as canonical runtime identity and evidence authority. — Python validates invariants while Rust and TypeScript compare actual startup inventories.
- [Phase 02]: Keep GATE-05 open until Plan 02-07 supplies release-receipt and asset authority. — Satisfied locally by Plan 02-07; deployed and operational proof remains separate.
- [Phase 02]: Operational release receipts reject test fixtures and bind canonical release tag, short-lived workflow/run identity, exact source, target profile and every required artifact digest.
- [Phase 02]: Pre-mutation authorization contains intended source, artifacts, selectors and rollback inputs; provider-returned deployment/source/status evidence is a separate post-deploy attestation.
- [Phase 02]: API and TypeScript are exact deployment roles with role-keyed rollback and manifest-owned health authority; biofield CV is topology-only.
- [Phase 02]: Deploy publication is limited to immutable source candidates; release publication is read-only and ends in an explicit HOLD until atomic multi-artifact authority exists.
- [Phase 02]: Required asset paths and tree digests are computed locally; production authorization requires source-bound image-inclusion attestation.
- [Phase 02]: Release receipt v1 covers container images only; native binary publication remains disabled pending per-platform digest authority.
- [Phase 02]: Vercel provider-side native deployment remains outside the repository gate, so production promotion stays HOLD.

## Blockers and Concerns

Draft recovery PR #1488 is open, draft and mergeable at evidence head `ba2d149106345bb9637e1d31fec8160e703c5501`. GitHub run 34046002390 passed all 16 jobs, including strict `CI Gate`; its pull-request merge tree is byte-identical to the branch tree. Ruleset 15597830 requires that strict check on main after explicit user approval and verified readback. The authoritative deep review reported ten Critical and four Warning findings; all have tested fixes or explicit fail-closed dispositions, and five independent rechecks ended with zero findings. Production mutation still requires durable one-use receipt consumption, Railway post-deploy attestation, atomic service/registry coordination, source-bound image asset attestation, real schema/rollback evidence and Vercel deployment protection, so promotion stays HOLD.

## Session Continuity

Resume from this file, the current ISA continuation criteria and Phase 3 issue #894. Phases 1 and 2 are verified. Phase 2 has complete local, independent-review and exact-head remote-CI evidence; both production profiles remain disabled until their named external authorities are proven. Begin Phase 3 in a fresh isolated `codex/selemene-contract-convergence` worktree from the verified recovery head, using the user-authorized recommended discussion defaults before research and planning.

Last session: 2026-09-06T16:50:15.000Z
Stopped At: Phase 02 verified complete; Phase 03 discussion and research next
Resume File: None
